Albuminuria Reduction Study With Survodutide Treatment in Kidney Disease
A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 120 participants.
Also called NCT07206290
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 120 participants
- Registry
-
NCT07206290 -
2025-523184-37-00
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07206290. Randomized; double masking; primary purpose treatment. Start 2026-03-02 (anticipated); primary completion 2027-11-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Albuminuria Reduction Study With Survodutide Treatment in Kidney Disease
- Acronym
- ARTIST-CKD
- Condition
- Chronic Kidney Disease
- Intervention (Drug)
- Survodutide (BI 456906)
- Intervention (Drug)
- Placebo
- Lead sponsor
- University Medical Center Groningen
Record details
- Record id
cardio:ct-nct07206290- Content hash
d88258f661c447315d0fc5c19097e511ffec73277aa83b2ddaa0d9bb6196c518